 |
- 1st production of pharmaceutical grade egg and milk challenge meals
- Product portfolio of challenge meals now includes peanut, milk and egg
- Innovation pipeline includes development of 'Top 9' allergen products as well as a products suitable from 6 months
DEESIDE, Wales, June 12, 2025 /PRNewswire/ -- May 2025 marked another key milestone for Reacta Healthcare, as the first production run of pharmaceutical grade milk and egg challenge meals commenced. These first orders will be shipped internationally for two clinical trials investigating novel food allergy treatments.
The importance of considering multiple food allergies in both diagnosis and treatment has become increasingly relevant. Amongst those with food allergies 46% of adults and 40% of children have multiple food allergies, making it crucial for healthcare providers to adopt a holistic approach.
The addition of egg and milk challenge meals to the existing peanut products at Reacta Healthcare reflects the prevalence of multiple food allergies. These products are designed to meet the needs of food allergy research and clinical communities, ensuring safety, quality, and efficacy across various allergens. The development of these new standardised allergen products allows for easy expansion of the product portfolio with further allergens.
Full development and manufacture of the new products has been undertaken at Reacta Healthcare's Medicines and Healthcare products Regulatory Agency (MHRA) licensed site in Deeside, UK. The challenge meals comply with client requirements for allergen identification, standardisation, and cGMP manufacturing. Successful submissions of these dossiers have been made to various health agencies including FDA and EMA on numerous occasions since 2017.
Reacta's challenge meals are suitable for supply to all phases of clinical trials for use in double-blind placebo-controlled oral food challenges. With the addition of 2 more allergens, Reacta is ideally placed to supply various challenge meal combinations to a growing clinical research community seeking an 'antigen agnostic' indication for their respective therapies. The multi-allergen site is now set up to seamlessly develop further allergen challenge meals, hazelnut and cashew prototypes have already been developed.
The company is utilising its internal research and development capabilities to advance food allergy research, diagnosis, and clinical practice.
ABOUT REACTA HEALTHCARE
Reacta Healthcare operates from a MHRA license pharmaceutical manufacturing facility in the UK. Their globally patented challenge meals are used in globally in therapeutic trials for the diagnosis and monitoring of food allergies.
- 1st production of pharmaceutical grade egg and milk challenge meals
- Product portfolio of challenge meals now includes peanut, milk and egg
- Innovation pipeline includes development of 'Top 9' allergen products as well as a products suitable from 6 months
DEESIDE, Wales, June 12, 2025 /PRNewswire/ -- May 2025 marked another key milestone for Reacta Healthcare, as the first production run of pharmaceutical grade milk and egg challenge meals commenced. These first orders will be shipped internationally for two clinical trials investigating novel food allergy treatments.
The importance of considering multiple food allergies in both diagnosis and treatment has become increasingly relevant. Amongst those with food allergies 46% of adults and 40% of children have multiple food allergies, making it crucial for healthcare providers to adopt a holistic approach.
The addition of egg and milk challenge meals to the existing peanut products at Reacta Healthcare reflects the prevalence of multiple food allergies. These products are designed to meet the needs of food allergy research and clinical communities, ensuring safety, quality, and efficacy across various allergens. The development of these new standardised allergen products allows for easy expansion of the product portfolio with further allergens.
Full development and manufacture of the new products has been undertaken at Reacta Healthcare's Medicines and Healthcare products Regulatory Agency (MHRA) licensed site in Deeside, UK. The challenge meals comply with client requirements for allergen identification, standardisation, and cGMP manufacturing. Successful submissions of these dossiers have been made to various health agencies including FDA and EMA on numerous occasions since 2017.
Reacta's challenge meals are suitable for supply to all phases of clinical trials for use in double-blind placebo-controlled oral food challenges. With the addition of 2 more allergens, Reacta is ideally placed to supply various challenge meal combinations to a growing clinical research community seeking an 'antigen agnostic' indication for their respective therapies. The multi-allergen site is now set up to seamlessly develop further allergen challenge meals, hazelnut and cashew prototypes have already been developed.
The company is utilising its internal research and development capabilities to advance food allergy research, diagnosis, and clinical practice.
ABOUT REACTA HEALTHCARE
Reacta Healthcare operates from a MHRA license pharmaceutical manufacturing facility in the UK. Their globally patented challenge meals are used in globally in therapeutic trials for the diagnosis and monitoring of food allergies.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Reacta Healthcare announces transformation into a facility for multi-allergen manufacturing
Reacta Healthcare announces transformation into a facility for multi-allergen manufacturing
Limited Edition Drop Features Iconic Jake Burton Quotes on Snowboards, Apparel & Accessories
BURLINGTON, Vt., Jan. 9, 2026 /PRNewswire/ -- Burton is proud to unveil 'From Burton to the World', a limited-edition collection of snowboards, apparel and accessories that feature iconic quotes by late Burton founder, Jake Burton Carpenter. Professional snowboarders sponsored by Burton will debut the collection as they compete in Aspen, Colorado and Laax, Switzerland this month, with global availability beginning February 3rd on Burton.com and at select flagship stores and retail partners worldwide.
"Jake built Burton on a simple belief: snowboarding brings people together," said Donna Carpenter, Burton Owner & Chair of the Board. "While we watch individual athletes compete, what Jake understood and what our riders embody is that snowboarding has always been about community. 'From Burton to the World' celebrates this spirit. Each board carries Jake's words, but more importantly, 'From Burton to the World' represents the passion snowboarders share on and off the mountain. This collection is a tribute to Jake's vision, which is now carried forward by riders around the world who continue to push the sport while staying true to its soul."
Jake's Words, Riders' Choice
Burton Team riders worked directly with designers to select the Jake Burton quotes that resonated most with them. The result: six bold, graphic snowboards in a vibrant color palette, each featuring history-making quotes in block print.
The Collection
'HAVE AS MUCH FUN AS POSSIBLE'
Ridden by: Oliver Martin (USA), Gaon Choi (Korea), Hiroto Ogiwara (Japan), Yiming Su (China), Mitsuki Ono (Japan), Nicola Liviero (Italy), Shaotong Wu (China) and Clemens Millauer (Austria).
'RIDING IS WHERE THE ENERGY COMES FROM & IT'S ALSO WHERE IT GOES'
Ridden by: Anna Gasser (Austria), Ayumu Hirano (Japan), Hanna Karrer (Austria), Reira Iwabuchi (Japan), Romain Allemand (France), Taiga Hasegawa (Japan) and Jakub Hrones (Czech Republic).
'HERE AT BURTON WE TAKE OUR FUN SERIOUSLY'
Ridden by: Brock Crouch (USA), Jiayu Liu (China), Jonas Hasler (Switzerland), Leon Vockensperger (Germany), Øyvind Kirkhus (Norway), Telma Sarkipajou (Finland), Dane Menzies (New Zealand), Zoi Sadowski-Synnott (New Zealand).
'THE BEST THING ABOUT SNOWBOARDING – IT'S NOT HOW YOU LOOK BUT HOW YOU FEEL'
Ridden by: Shuichiro Shigeno (Japan).
'BELIEVE IN SNOWBOARDING'
Ridden by: Kaishu Hirano (Japan).
'QUESTION: IS SNOWBOARDING A FAD? ANSWER: GET SERIOUS'
Ridden by: Cam Melville Ives (New Zealand), Clemens Millauer (Austria), Lu Yang (China), Mark McMorris (Canada) and Mari Fukada (Japan).
Supporting the Riders, Celebrating the Community
Burton is proud to support this incredible global community of riders who carry forward Jake's vision every time they drop in. Fans can celebrate alongside Burton riders and own a piece of snowboarding history with the 'From Burton to the World' collection of snowboards, apparel, and accessories—available in limited quantities worldwide beginning February 3rd on Burton.com and at select Burton flagship stores and retail partners.
Photo - https://mma.prnasia.com/media2/2857988/Burton_Riders_Debut.jpg?p=medium600
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Burton Riders Debut 'From Burton to the World' Collection in Aspen & Laax
